ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making, ultimately helping to make therapies available to address patients’ unmet needs.
Similar Posts
JKR Pharmacy Ventures, LLC dba Doc Lane’s Veterinary Pharmacy. Lexington, KY. 483 issued 12/19/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 12/19/2025
Short Title (70 char) JKR Pharmacy Ventures, LLC dba Doc Lane’s Veterinary Pharmacy. Lexington, KY. 483 issued 12/19/2025
FEI Number 3033262505
Firm Name JKR Pharmacy Ventures, LLC
Record Type 483
StaSymptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment
Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for TreatmentEarly Alert: Heart Pump Purge Cassette Issue from Abiomed
Impella Generation 1 Purge Cassettes have an increased risk of purge leaks. Purge leaks can lead to low pump pressure and pump stopsCheck Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
Prescription drugs should only be purchased from wholesale drug distributors licensed in the United States. Verify licensing through FDA database links.Primary Care Providers Can Prescribe with Confidence
Information and resources are available to help primary care providers manage OUD with the help of medications for opioid use disorder (MOUD).Olympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment
CENTER VALLEY, Pa., (October 31, 2025) – Olympus Corporation has announced a voluntary, global medical device corrective action to provide further clarification on the safe and effective use of bronchoscopes with laser therapy, argon plasma coagulation or high-frequency cauterization equipment durin